selective factor Xia serine protease inhib.

oral, phase II, cardiovascular

from opt. of previous macrocyclic FXIa inh.

Journal of Medicinal Chemistry

Bristol Myers Squibb

Chemical structure of molecule Milvexian BMS-986177

The BMS factor XIa inhibitor, milvexian (BMS-986177), is an oral antithrombotic with a Ki of 0.11 nM. A member of this macrocyclic series was previously highlighted as one of 2020’s Molecules of…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: